Medical Devices Canada

Canada Hemostats and Sealants Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Canada Hemostats and Sealants Market Industry Trends and Forecast to 2034: Segmented by (Product, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Canada · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $596.4 Mn Placeholder estimate
Estimate 2025 $639.3 Mn 8.6% of the global market
Projected 2034 $1.20 Bn 87% Adds $555.9 Mn over 9 forecast years
CAGR 2025–2034 7.2% Faster than 37% of 180 Medical Devices markets here
Key players 5
  • Canada is 8.59% of the global market.
  • In North America, the largest is US at $3.42 Bn.
  • Fastest growing: Canada (this report) at 7.2% a year.
  • Canada ranks 2nd of 2 by size in North America.

Market size projection

Canada

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$555.9 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Hemostats and Sealants Market market size by year, Canada
YearMarket sizeChange that yearSince 2025
2024 (estimate) $596.4 Mn — —
2025 (base) $639.3 Mn +$42.9 Mn —
2026 (forecast) $685.3 Mn +$46.0 Mn +7.2%
2027 (forecast) $734.7 Mn +$49.3 Mn +14.9%
2028 (forecast) $787.6 Mn +$52.9 Mn +23.2%
2029 (forecast) $844.3 Mn +$56.7 Mn +32.1%
2030 (forecast) $905.0 Mn +$60.8 Mn +41.6%
2031 (forecast) $970.2 Mn +$65.2 Mn +51.8%
2032 (forecast) $1.04 Bn +$69.9 Mn +62.7%
2033 (forecast) $1.11 Bn +$74.9 Mn +74.4%
2034 (forecast) $1.20 Bn +$80.3 Mn +87%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Canada Hemostats and Sealants Market Analysis at a glance
Market size, 2025$639.3 Mn placeholder estimate
Forecast, 2034$1.20 Bn placeholder estimate
Growth (CAGR), 2025–20347.2% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
Also calledHemostasis and Tissue Sealing Agents
SegmentsProduct, application and end user (see all)
Key playersBaxter International, Johnson & Johnson, BD (Becton, Dickinson), CSL Behring, Integra Life Sciences Corporation (see all)
Regulator in CanadaHealth CanadaSource: Health Canada. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Canada Hemostats and Sealants Market Analysis Executive Summary

Hemostats and sealants stop bleeding and seal tissue during surgery, using powders, patches and glues.

Key segments of the hemostats and Sealants market include product (Thrombin-Based, Gelatin-Based and Fibrin Sealants) and application (Cardiovascular, General Surgery and Orthopedic).

Bar chart: Canada Hemostats and Sealants market size, 2024–2034, placeholder estimates. $596.4 Mn in 2024, $639.3 Mn in 2025 and $1.20 Bn in 2034, 7.2% CAGR.
Canada Hemostats and Sealants market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Canada Hemostats and Sealants Market Dynamics

Market Growth Drivers

Demand for less invasive surgery, shorter hospital stays, surgeon shortages and improvements in robotics, imaging and AI are driving the hemostats and Sealants market.

Opportunity

Smaller and cheaper systems, outpatient surgery centres and use in emerging markets give the hemostats and Sealants market room to grow.

Market Restraints

High purchase and maintenance costs, training needs and limited proof of better outcomes for some procedures hold back the hemostats and Sealants market.

Competitive Landscape for Hemostats and Sealants Market in Canada

The hemostats and Sealants market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Hemostats and Sealants Market in Canada

Hemostats and Sealants in Canada: rules and payment

Health Canada licenses Class II, III and IV medical devices; Class I devices are sold by companies that hold an establishment licence.⁠[1] Each province and territory runs public health insurance under the Canada Health Act, which covers medically necessary hospital and doctor services.⁠[2]

[1] Health Canada. Checked 14 Nov 2026.

[2] Health Canada. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how hemostats and Sealants products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Canada.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Hemostats and Sealants right now, from free public sources.

Latest research 11 papers since 2021 (worldwide)

  1. Biocompatibility of mussel-inspired water-soluble tissue adhesives. Journal of biomedical materials research. Part A, 2024
  2. Coacervation-triggered hierarchically assembled hydrogels with application as surgical sealant. Biofabrication, 2023
  3. One-Pot Extraction of Bioresources from Human Hair via a Zero-Waste Green Route. ACS omega, 2023
  4. Hemostatic Agents in Orthopedic Surgery. HSS journal : the musculoskeletal journal of Hospital for Special Surgery, 2022
  5. Polymer nanomaterials for use as adjuvant surgical tools. Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology, 2023
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Hemostats and Sealants in context

Canada compared

  • Health spending per person: 6,378 US$ per person (2024). World: 1,317 US$ per person (2023).[1]
  • Doctors: 2.82 per 1,000 people (2023). World: 1.86 per 1,000 people (2022).[2]
  • People aged 65 and over: 20.3% of people (2025). World: 10.4% of people (2025).[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 20 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 20 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 21 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Hemostats and Sealants market in Canada?
Placeholder estimate: about $639.3 Mn in 2025, rising to about $1.20 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Hemostats and Sealants market in Canada growing?
Placeholder estimate: about 7.2% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Hemostats and Sealants market report cover?
The report splits the market by product (Thrombin-Based, Gelatin-Based, Fibrin Sealants, Synthetic Sealants), application (Cardiovascular, General Surgery, Orthopedic, Neurosurgery) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Hemostats and Sealants market?
Key players include Baxter International, Johnson & Johnson, BD (Becton, Dickinson), CSL Behring and Integra Life Sciences Corporation.
What is driving the Hemostats and Sealants market?
Demand for less invasive surgery, shorter hospital stays, surgeon shortages and improvements in robotics, imaging and AI are driving the hemostats and Sealants market.
Who regulates Hemostats and Sealants in Canada?
Health Canada licenses Class II, III and IV medical devices; Class I devices are sold by companies that hold an establishment licence. Source: Health Canada. Checked 14 Nov 2026.
How is healthcare paid for in Canada?
Each province and territory runs public health insurance under the Canada Health Act, which covers medically necessary hospital and doctor services. Source: Health Canada. Checked 14 Nov 2026.
How much research is published on Hemostats and Sealants?
PubMed lists 11 papers on Hemostats and Sealants added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Canada

See all

Related on surgery and wounds and burns

See the topic